Efficient continuous
Grignard and lithiation processes were developed
to produce one of the key regulatory starting materials for the production
of edivoxetine hydrochoride. For the Grignard process, organometallic
reagent formation, Bouveault formylation, reduction, and workup steps
were run in continuous stirred tank reactors (CSTRs). The lithiation
utilized a hybrid approach where plug flow reactors (PFRs) were used
for the metal halogen exchange and Bouveault formylation steps, while
the reduction and workup steps were performed in CSTRs. Relative to
traditional batch processing, both approaches offer significant advantages.
Both processes were high-yielding and produced the product in high
purity. The two main processes were directly compared from a number
of perspectives including reagent and operational safety, fouling
potential, process footprint, need for manual operation, and product
yield and purity.